Diagnostic and Management of Hand Infection.
HandInf
1 other identifier
observational
1,400
1 country
1
Brief Summary
Primary or secondary (post-traumatic infections, notably related to bites, wounds, etc.) infections of the hand are very common situations, even if the epidemiology is poorly understood. For example, hand bite injuries represent 1.2 million referrals to the healthcare system per year in the United States. Their nosological framework extends from simple infections of the skin and soft tissues such as whitlows, to potentially severe deep damage such as arthritis and osteitis, or phlegmons of the tendon sheaths. The diagnostic approach is not consensual, and the contribution of additional biological parameters (inflammatory syndrome) and morphological investigations (x-rays, ultrasound, CT-scan or MRI) is not codified. Microbiology seems dominated by Staphylococcus aureus, but few studies have precisely described the microbial etiology. Consequently, probabilistic antibiotic therapy and the need to take bacteriological samples for secondary adaptation are not standardized. Likewise, surgical strategies (abstention, systematic washing or depending on evolution) remain operator dependent. We consequently aim to described diagnostic, management and related outcomes or hand infections in a specialized tertiary care center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 26, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedOctober 8, 2024
October 1, 2024
4 months
September 26, 2024
October 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of treatment failure during the management of hand infections.
Treatment failure will be defined as infection persistence or relapse, need of unplanned surgery for septic reason or infection-related death.
between 01/01/2014 and 31/12/2023.
Study Arms (1)
Hand infection
Description of whitlows, tendinous infections and septic arthritis diagnostic, management and outcome Descriptive study, no intervention
Interventions
Describe the management failure rate for hand infections, including panariasis, phlegmons and arthritis.
Eligibility Criteria
Patients will be selected from the data base of the hand emergency surgery department of our tertiary care center, based on a principal or secondary diagnosis of BJI appearing alone or in combination with either sepsis or a specific surgical procedure - 1400 potential patients.
You may qualify if:
- all patient ≥ 18
- yo followed-up for a hand infection in our tertiary care center
- from 01/01/2014 to 31/12/2023, including
- whitlows
- tendinous infections
- septic arthritis
You may not qualify if:
- osteomyelitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HCL - Hôpital Edouard Herriot
Lyon, 69003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florent Valour Pr Florent Valour, Pr
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2024
First Posted
October 8, 2024
Study Start
September 1, 2024
Primary Completion
December 31, 2024
Study Completion
June 30, 2025
Last Updated
October 8, 2024
Record last verified: 2024-10